A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis

20001,751 citationsJournal Articlebronze Open Access

Authors

Joan M. Bathon · Johns Hopkins University

Richard W. Martin · Michigan State University

Roy Fleischmann · Metroplex Clinical Research Center

John Tesser

Michael Schiff · Denver Arthritis Clinic

Edward Keystone · Mount Sinai Hospital

Mark C. Genovese · Stanford University

Abstract

As compared with oral methotrexate, subcutaneous [corrected] etanercept acted more rapidly to decrease symptoms and slow joint damage in patients with early active rheumatoid arthritis.

Topics & Keywords

Rheumatoid Arthritis Research and Therapies Autoimmune and Inflammatory Disorders Research Musculoskeletal synovial abnormalities and treatments

Publication Details

Published in: New England Journal of Medicine

Volume 343, Issue 22, pp. 1586-1593

DOI: 10.1056/nejm200011303432201

Field-Weighted Citation Impact: 85.66

Command Palette

A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis

Authors

Abstract

Topics & Keywords

Publication Details